Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015652 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | AMPH | Petersen Floyd F. | Dir | A - Grant | $0.00 | +3,076 | 81.4K | +4% | $0 |
| D | 2024-06-05 | 2024-06-03 | AMPH | Petersen Floyd F. | Dir | S - Sale | $42.65 | -500 | 78.3K | -0.6% | -$21.3K |
| D | 2024-06-05 | 2024-06-03 | AMPH | Petersen Floyd F. | Dir | A - Grant | $0.00 | +6,864 | 6,864 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | A | A | 3,076 | $0.00 | 81,409 | D | — | — | (F3) The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 3, 2025. |
| 2 | Common | Common Stock | 2024-06-03 | S | D | 500 | $42.65 | 78,333 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.26 to $42.945, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2024-06-03 | A | A | 6,864 | $0.00 | 6,864 | D | $42.25 · — to 2034-06-03 | 6,864 Common Stock | (F4) All of the shares subject to the option vest on June 3, 2025. |